1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
PolyBio Research Foundation Grants is sponsored by PolyBio Research Foundation. The PolyBio Research Foundation advances research on how viral, bacterial, and parasite infections drive chronic disease and aging. They build collaborative projects that identify, diagnose, and treat root causes of infection-associated chronic illness, with focus areas including Long COVID and Chronic Lyme Disease.
Get alerted about grants like this
Save a search for “PolyBio Research Foundation” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Researchers and institutions focused on how viral, bacterial, and parasite infections drive chronic disease and aging. Confirm the full requirements in the official notice before applying.
PolyBio Research Foundation Grants is funded by PolyBio Research Foundation. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Long COVID Research Grant is a grant from the PolyBio Research Foundation that funds scientific research aimed at understanding and curing Long COVID. The program supports the Long COVID Cure Initiative (LCCI), which focuses on accelerating translation of academic findings into diagnostic tests, targeted clinical trials, and patient-ready therapies. Research priorities include viral persistence mechanisms, immune system dysregulation, microbiome disruption, and downstream consequences such as blood clotting, myocarditis, and neurological impairment. Eligible applicants include universities, research institutions, and nonprofit organizations. Individual awards have reached $575,000 for qualifying research projects.
Long COVID Cure Initiative (LCCI) is sponsored by PolyBio Research Foundation. This initiative aims to deliver treatments to Long COVID patients by translating academic findings into diagnostics and therapies. Research on viral persistence or viral components in the context of Long COVID, which could involve aspects of virus assembly, might be relevant.
PolyBio Long COVID Cure Initiative (LCCI) is sponsored by PolyBio Research Foundation (with support from Park-Pagliuca Fund and Balvi Fund). The LCCI is designed to deliver treatments to millions of Long COVID patients by translating key academic findings into real-world diagnostic tests, faster and more targeted clinical trials, and accessible, patient-ready therapies. While specifically for Long COVID, the focus on diagnostics and therapies for viral infections makes it potentially relevant.